HTR2A Gene Set

Dataset Pathway Commons Protein-Protein Interactions
Category physical interactions
Type interacting protein
Description 5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled|This gene encodes one of the receptors for serotonin, a neurotransmitter with many roles. Mutations in this gene are associated with susceptibility to schizophrenia and obsessive-compulsive disorder, and are also associated with response to the antidepressant citalopram in patients with major depressive disorder (MDD). MDD patients who also have a mutation in intron 2 of this gene show a significantly reduced response to citalopram as this antidepressant downregulates expression of this gene. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2009] (NCBI Entrez Gene Database, 3356)
External Link http://www.ncbi.nlm.nih.gov/gene/3356
Similar Terms
Downloads & Tools

Genes

20 interacting proteins for HTR2A from the Pathway Commons Protein-Protein Interactions dataset.

Symbol Name
ANKS1B ankyrin repeat and sterile alpha motif domain containing 1B
CBL Cbl proto-oncogene, E3 ubiquitin protein ligase
DLG4 discs, large homolog 4 (Drosophila)
EIF3F eukaryotic translation initiation factor 3, subunit F
GLUL glutamate-ammonia ligase
GNA11 guanine nucleotide binding protein (G protein), alpha 11 (Gq class)
GNAI1 guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 1
GNAQ guanine nucleotide binding protein (G protein), q polypeptide
GRM2 glutamate receptor, metabotropic 2
JAK2 Janus kinase 2
LYN LYN proto-oncogene, Src family tyrosine kinase
MAP1A microtubule-associated protein 1A
MPDZ multiple PDZ domain protein
MRPL28 mitochondrial ribosomal protein L28
NDUFB10 NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 10, 22kDa
NME3 NME/NM23 nucleoside diphosphate kinase 3
NTRK3 neurotrophic tyrosine kinase, receptor, type 3
PON2 paraoxonase 2
PPP5C protein phosphatase 5, catalytic subunit
RPS6KA3 ribosomal protein S6 kinase, 90kDa, polypeptide 3